These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8438440)

  • 1. One-year follow-up results of a phase I trial of mycophenolate mofetil (RS61443) in cadaveric renal transplantation.
    Deierhoi MH; Sollinger HW; Diethelm AG; Belzer FO; Kauffman RS
    Transplant Proc; 1993 Feb; 25(1 Pt 1):693-4. PubMed ID: 8438440
    [No Abstract]   [Full Text] [Related]  

  • 2. A single center experience with mycophenolate mofetil in the prevention of renal allograft rejection.
    Behrend M; Lück R; Köthe P; Pichlmayr R
    Transplant Proc; 1996 Dec; 28(6):3110-1. PubMed ID: 8962205
    [No Abstract]   [Full Text] [Related]  

  • 3. Mycophenolate mofetil for prevention of acute rejection.
    Moore R; Griffin P; Darby C; Jurewicz A; Lord R
    Lancet; 1995 Jul; 346(8969):253. PubMed ID: 7616827
    [No Abstract]   [Full Text] [Related]  

  • 4. Mycophenolate mofetil improves long-term graft survival following renal transplantation in patients experiencing delayed graft function. International Mycophenolate Mofetil Renal Study Groups.
    Cho S; Hodge E; Navarro M
    Transplant Proc; 1999; 31(1-2):322-3. PubMed ID: 10083126
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of tacrolimus and mycophenolate mofetil for pancreas-kidney transplantation with or without OKT3 induction.
    Burke GW; Ciancio G; Alejandro R; Roth D; Ricordi C; Tzakis A; Miller J
    Transplant Proc; 1998 Jun; 30(4):1544-5. PubMed ID: 9636627
    [No Abstract]   [Full Text] [Related]  

  • 6. Mycophenolate mofetil with lower cyclosporine dose in high-risk renal transplant recipients.
    Esmeraldo RM; Donadi MO; Oliveira ML; Ponte CN; Pinheiro PM
    Transplant Proc; 1999 Nov; 31(7):3007-8. PubMed ID: 10578367
    [No Abstract]   [Full Text] [Related]  

  • 7. Combining FK 506 and mycophenolate mofetil for the treatment of acute corticosteroid-resistant rejection following kidney transplantation: a new therapeutic concept.
    Carl S; Dörsam J; Mandelbaum A; Staehler G; Wiesel M
    Transplant Proc; 1998 Jun; 30(4):1236-7. PubMed ID: 9636502
    [No Abstract]   [Full Text] [Related]  

  • 8. RS-61443: a new immunosuppressive agent.
    Young CJ; Sollinger HW
    Transplant Proc; 1994 Dec; 26(6):3144-6. PubMed ID: 7998096
    [No Abstract]   [Full Text] [Related]  

  • 9. Mycophenolate mofetil immunosuppressive therapies increase the incidence of cytomegalovirus infection in renal transplantation.
    Munoz MA; Andrés A; Gallego R; Morales E; Morales JM; Aguado JM; Lumbreras C; Torres A; Rodicio JL; Praga M
    Transplant Proc; 2002 Feb; 34(1):97. PubMed ID: 11959202
    [No Abstract]   [Full Text] [Related]  

  • 10. Improved primary transplant success rates using a triple regimen of cyclosporine microemulsion, mycophenolate mofetil and prednisone.
    Khauli RB; Medawar WA; Habbal AA; Birbari AE; Daouk MM; Abdelnoor AM; Uwaydah M; Rahman Bizri A; Sanjad S; Ayvazian PJ; Lovewell T; Stoff JS; Yang Fan P; Bigwood P; Harland R
    Transplant Proc; 2001 Aug; 33(5):2776-7. PubMed ID: 11498156
    [No Abstract]   [Full Text] [Related]  

  • 11. The incidence of subsequent acute rejection following the treatment of refractory renal allograft rejection with mycophenolate mofetil (RS61443).
    Laskow DA; Deierhoi MH; Hudson SL; Orr CL; Curtis JJ; Diethelm AG
    Transplantation; 1994 Feb; 57(4):640-3. PubMed ID: 8116055
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of recurrent heart rejection with mycophenolate mofetil (RS-61443): initial clinical experience.
    Kirklin JK; Bourge RC; Naftel DC; Morrow WR; Deierhoi MH; Kauffman RS; White-Williams C; Nomberg RI; Holman WL; Smith DC
    J Heart Lung Transplant; 1994; 13(3):444-50. PubMed ID: 8061021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simulect, calcineurin inhibitor, mycophenolate mofetil, and prednisone is more effective than OKT3, calcineurin inhibitor, hycophendate mofetil, and prednisone in African American kidney recipients in reducing acute rejections and prolonging graft survival.
    Kumar AM; Fa K; Vankawala R; Vora M; Kode RK; Pankewycz OG; Lattavi MR; Fyfe B; Damask AM; Ferry E; Stabler S; Tomeny MB; Phillips K; Lingaraju R; Kumar MS
    Transplant Proc; 2001; 33(7-8):3195-6. PubMed ID: 11750370
    [No Abstract]   [Full Text] [Related]  

  • 14. Experience with mycophenolate mofetil (RS61443) in renal transplantation at a single center.
    Deierhoi MH; Kauffman RS; Hudson SL; Barber WH; Curtis JJ; Julian BA; Gaston RS; Laskow DA; Diethelm AG
    Ann Surg; 1993 May; 217(5):476-82; discussion 482-4. PubMed ID: 8489310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive effect of mycophenolate mofetil with two different dosages in cadaveric renal transplantation: a short study.
    Wang X; Tang X; Xu D
    Transplant Proc; 1998 Nov; 30(7):3573-4. PubMed ID: 9838564
    [No Abstract]   [Full Text] [Related]  

  • 16. Mofetil mycophenolate in renal transplantation.
    Pretagostini R; Rossi M; Berloco P; Colonnello M; Bruzzone P; Peritore D; Lonardo MT; Cortesini R
    Transplant Proc; 2001; 33(1-2):1082-3. PubMed ID: 11267200
    [No Abstract]   [Full Text] [Related]  

  • 17. Reversal of chronic rejection after treatment failure with FK506 and RS61443.
    Roberts JP; Lake JR; Hebert M; Nikolai B; Ascher NL; Ferrell LD
    Transplantation; 1993 Oct; 56(4):1021-3. PubMed ID: 7692634
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacoeconomic analysis of mycophenolate mofetil versus azathioprine in primary cadaveric renal transplantation.
    Baker GM; Martin JE; Jang R; Schroeder TJ; Armitstead JA; Myre S; First MR
    Transplant Proc; 1998 Dec; 30(8):4082-4. PubMed ID: 9865304
    [No Abstract]   [Full Text] [Related]  

  • 19. Induction strategy using basiliximab combined with mycophenolate MMF and immediate low-dose cyclosporin is steroid sparing and more effective than OKT3.
    Chowdhury S; Kode RK; Ranganna K; Damask AM; Lam A; Fyfe B; Stabler S; Kumar AM; Tomeny MB; Kumar MS; Pankewycz O
    Transplant Proc; 2001; 33(1-2):1057-8. PubMed ID: 11267189
    [No Abstract]   [Full Text] [Related]  

  • 20. Pilot study of mycophenolate mofetil (RS-61443) in the prevention of acute rejection following renal transplantation in Japanese patients. RS-61443 Investigation Committee--Japan.
    Takahashi K; Ochiai T; Uchida K; Yasumura T; Ishibashi M; Suzuki S; Otsubo O; Isono K; Takagi H; Oka T
    Transplant Proc; 1995 Feb; 27(1):1421-4. PubMed ID: 7878933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.